86-027-88210112
Quick detail
Product name: SR9011
Other name:Stenabolic
CAS: 1379686-29-9
Appearance: White powder
purity: 99%
Trademark: Pharmlab
Original: China
Grade: Pharmaceutical grade
Package: Disguised package ; Foil bag
Delivery date: 3-5 work days
Certificate: ISO 9001, USP,GMP
Payment: Western Union, MoneyGram, T/T, bitcoin
Shipping: EMS,HKEMS,EUB,ETK,FEDEX,DHL,UPS,Aramex,ETC
Molecular formular: C20H24ClN3O4S
Molecular Weight: 437.94
Application: SR9011 increase exercise endurance and loss weight.
Usage:reduce mass fat
Product description
SR9011 is a trifunctional methacrylate monomer that provides excellent adhesion to metal substrates. SR9011 is recommended for peroxide curing coatings, sealants and PVC-based plastisols. Suggested usage is 5% to 10%.
SR9011 is an effective and specific synthetic REV-ERB agonist that binds REV-ERB-α of EC50 to 790 nM and REV-ERB-[beta] of EC50 to 560 nM. It also has good in vivo plasma / brain exposure. Nuclear receptors REV-ERB-α and REV-ERB-β play an indispensable role in regulating the expression of core clock proteins, promoting rhythms in activity and metabolism. The administration of SR9011 changed the circadian rhythm patterns of circadian rhythm behavior and core clock gene expression in the hypothalamus of mice. Liver, skeletal muscle and adipose tissue in a series of metabolic genes circadian rhythm expression pattern also changed, resulting in increased energy consumption. Treatment of Diet-induced obese mice with SR9011 reduces fat levels by reducing fat consumption, significantly improving dyslipidemia and hyperglycemia. These results suggest that pharmacological targeting of circadian rhythms of synthetic REV-ERB ligands may be beneficial in the treatment of sleep disorders as well as metabolic diseases.
Prodcut application
The new compounds known as SR9011 can increase laboratory metabolism, fat burning and muscle growth.
Scientists at the Scripps Institute (TSRI) have successfully tested a drug called SR9011,
In mice that initiate metabolism and lead to increased muscle development.
In essence, this is a pill of the sport system.
SR9011 changes the metabolic characteristics of skeletal muscle in a similar manner to the observed changes,
Animal training has endurance. Basically, the drug sends a signal to the muscle and tells it to modify it
Its metabolism.
Half of the mice studied showed improved run endurance in terms of time and distance. Obviously, a small drug-like molecule can increase the metabolic rate of skeletal muscle, increase exercise tolerance
SR9011 Uses
The new compounds known as SR9011 can increase laboratory metabolism, fat burning and muscle growth.
Scientists at the Scripps Institute (TSRI) have successfully tested a drug called SR9011,
In mice that initiate metabolism and lead to increased muscle development.
In essence, this is a pill of the sport system.
SR9011 changes the metabolic characteristics of skeletal muscle in a similar manner to the observed changes,
Animal training has endurance. Basically, the drug sends a signal to the muscle and tells it to modify it
Its metabolism.
Half of the mice studied showed improved run endurance in terms of time and distance. Obviously, a small drug-like molecule can increase the metabolic rate of skeletal muscle, increase exercise tolerance
SR9011 is not just a "diet" pill
There is no way to sugar - although many people try - keeping healthy weight may be difficult. Because it is difficult, many people try the "miracle" diet pills and other quick fixes that ultimately need to change the way of life. Many non-prescription diets and diet pills are unregulated
And may contain hazardous ingredients. However, SR9011 is not like an appetite suppressant, laxative or "fat blocker". You will not find SR9011 in the list of ingredients for protein powder or exercise supplements.
The difference between SR9009 and other diet pills is its chemical composition. SR9011 is not appetite
Inhibitors - Many weight loss drugs - directly by increasing the metabolic rate of muscle. Your metabolism accelerates and naturally slows down during the day, which means that sometimes food is used for energy, and sometimes it is stored as fat. By resynchronizing the abnormal function of the metabolic clock, the SR9011 ensures that food and excess fat are used as energy.
SR9011 is one of Burris and his team developed at TSRI. The drug binds to Rev-erbα, a natural protein that affects liver lipids and glucose metabolism, inflammatory responses, and fat-storing cells in vivo. By combining with Rev-erbα, the SR9011 can initiate metabolism and another pleasant side effect: increase muscle strength.
How to run
SR9009 treatment showed increased endurance and reverse mitochondrial damage studies.R9009 in improving athletic ability and endurance has great prospects. This compound acts as an agonist for Rev-erbα. SR9009 binds to a natural molecule of the body called Rev-erbα that affects lipid and glucose metabolism in the liver, the production of fat-storing cells, and the response of macrophages (cells that remove dead or dead cells) during inflammation.
Current studies have shown that activation of Rev-erbα in SR9009 results in an increase in skeletal muscle metabolic activity and a 50% increase in exercise capacity, both measured by time and distance. R9009 is an easy-to-use oral compound that promotes metabolism Activities of the current study.
Stenabolic / SR9009 Dosage
Users report the amount of 20-100mg daily, without any negative impact. From the information we received, the results of SR9009 treatment appear to be dose-dependent, with a maximum dose of 100 mg per day. At this dose, the results tend to decrease gradually.
Sarm Steroid we offer
Sarms | CAS No. | Function |
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 | therapy for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine, MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
SR9011 | 1379686-29-9 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
Yk11 | 366508-78-3 431579-34-9 | YK11: a SARM and myostatin inhibitor in one |
Welcome to contact Miss Alsia
Skype:live:mxy04
Whatsapp:+8615107134681
Mobilephone:+8615107134681
facebook:www.facebook.com/alisa.lee.58118
Email:marc@chembj.com